Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$1.48
$1.29
$1.05
$9.05
$100.01M-0.13355,606 shs97,970 shs
CryoPort, Inc. stock logo
CYRX
CryoPort
$7.98
+2.2%
$6.87
$4.58
$9.66
$391.57M1.89440,149 shs604,880 shs
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$15.37
+0.5%
$15.99
$3.25
$21.48
$410.04M1.18654,254 shs448,049 shs
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
$1.78
-4.8%
$1.33
$0.66
$1.94
$425.05M1.863.44 million shs3.39 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Climb Bio, Inc. stock logo
CLYM
Climb Bio
+4.96%+5.71%+23.33%+13.85%+147,999,900.00%
CryoPort, Inc. stock logo
CYRX
CryoPort
+5.11%+4.83%+19.05%+32.60%-13.51%
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
+4.80%+10.08%+13.18%-3.17%+330.70%
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
+8.72%+12.65%+36.50%+90.97%+74.77%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Climb Bio, Inc. stock logo
CLYM
Climb Bio
2.614 of 5 stars
3.60.00.00.00.62.51.3
CryoPort, Inc. stock logo
CYRX
CryoPort
2.0844 of 5 stars
3.41.00.00.02.82.50.0
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
2.4704 of 5 stars
3.51.00.00.03.31.70.6
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
3.5284 of 5 stars
3.51.00.04.71.11.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Climb Bio, Inc. stock logo
CLYM
Climb Bio
3.25
Buy$9.00508.11% Upside
CryoPort, Inc. stock logo
CYRX
CryoPort
2.78
Moderate Buy$11.1139.24% Upside
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3.00
Buy$29.6793.02% Upside
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
3.00
Buy$8.25363.48% Upside

Current Analyst Ratings Breakdown

Latest CLYM, GOSS, CYRX, and ETON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/22/2025
CryoPort, Inc. stock logo
CYRX
CryoPort
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeOverweight$13.00
7/14/2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Outperform$11.00
7/7/2025
CryoPort, Inc. stock logo
CYRX
CryoPort
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $10.00
6/6/2025
Climb Bio, Inc. stock logo
CLYM
Climb Bio
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$10.00
5/29/2025
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$33.00 ➝ $35.00
5/22/2025
Climb Bio, Inc. stock logo
CLYM
Climb Bio
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
5/22/2025
Climb Bio, Inc. stock logo
CLYM
Climb Bio
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$7.00
5/16/2025
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$24.00 ➝ $26.00
5/16/2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $8.00
5/16/2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$4.00 ➝ $4.00
5/14/2025
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$26.00 ➝ $28.00
(Data available from 7/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Climb Bio, Inc. stock logo
CLYM
Climb Bio
N/AN/AN/AN/A$3.15 per shareN/A
CryoPort, Inc. stock logo
CYRX
CryoPort
$232.13M1.72N/AN/A$7.44 per share1.07
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$39.01M10.57N/AN/A$0.94 per share16.35
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
$114.70M3.53N/AN/A$0.13 per share13.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Climb Bio, Inc. stock logo
CLYM
Climb Bio
-$73.90M-$2.38N/AN/AN/AN/A-43.95%-42.94%8/13/2025 (Estimated)
CryoPort, Inc. stock logo
CYRX
CryoPort
-$114.76M-$2.34N/AN/AN/A-50.15%-11.03%-5.54%8/5/2025 (Estimated)
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
-$3.82M-$0.18N/A30.74N/A-9.49%-3.15%-1.08%8/4/2025 (Estimated)
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
-$56.53M-$0.23N/AN/AN/A-41.12%-128.98%-15.52%8/11/2025 (Estimated)

Latest CLYM, GOSS, CYRX, and ETON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
-$0.02N/AN/AN/AN/AN/A
8/13/2025Q2 2025
Climb Bio, Inc. stock logo
CLYM
Climb Bio
-$0.19N/AN/AN/AN/AN/A
8/11/2025Q2 2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
-$0.18N/AN/AN/A$4.12 millionN/A
8/5/2025Q2 2025
CryoPort, Inc. stock logo
CYRX
CryoPort
-$0.20N/AN/AN/A$41.74 millionN/A
5/15/2025Q1 2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
-$0.18-$0.16+$0.02-$0.16$3.95 million$9.89 million
5/14/2025Q1 2025
Climb Bio, Inc. stock logo
CLYM
Climb Bio
-$0.15-$0.31-$0.16-$0.31N/AN/A
5/13/2025Q1 2025
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$0.09$0.07-$0.02-$0.06$14.33 million$17.28 million
5/7/2025Q1 2025
CryoPort, Inc. stock logo
CYRX
CryoPort
-$0.23-$0.22+$0.01-$0.28$56.19 million$41.04 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Climb Bio, Inc. stock logo
CLYM
Climb Bio
N/AN/AN/AN/AN/A
CryoPort, Inc. stock logo
CYRX
CryoPort
N/AN/AN/AN/AN/A
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
N/AN/AN/AN/AN/A
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Climb Bio, Inc. stock logo
CLYM
Climb Bio
N/A
14.25
14.25
CryoPort, Inc. stock logo
CYRX
CryoPort
0.51
5.56
5.24
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
1.23
1.97
1.43
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
6.70
5.71
5.71

Institutional Ownership

CompanyInstitutional Ownership
Climb Bio, Inc. stock logo
CLYM
Climb Bio
69.76%
CryoPort, Inc. stock logo
CYRX
CryoPort
92.90%
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
27.86%
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
81.23%

Insider Ownership

CompanyInsider Ownership
Climb Bio, Inc. stock logo
CLYM
Climb Bio
0.80%
CryoPort, Inc. stock logo
CYRX
CryoPort
10.00%
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
16.03%
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
6.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Climb Bio, Inc. stock logo
CLYM
Climb Bio
967.58 million67.04 millionN/A
CryoPort, Inc. stock logo
CYRX
CryoPort
1,18650.14 million45.12 millionOptionable
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
2026.82 million22.52 millionOptionable
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
180227.30 million212.07 millionOptionable

Recent News About These Companies

Gossamer Bio (NASDAQ:GOSS) Coverage Initiated at Scotiabank
Q1 2025 Gossamer Bio Inc Earnings Call

New MarketBeat Followers Over Time

Media Sentiment Over Time

Climb Bio stock logo

Climb Bio NASDAQ:CLYM

$1.48 0.00 (0.00%)
As of 04:00 PM Eastern

Climb Bio Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company's lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody which has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. Climb Bio Inc., formerly known as Eliem Therapeutics Inc., is based in WELLESLEY, Mass.

CryoPort stock logo

CryoPort NASDAQ:CYRX

$7.98 +0.17 (+2.18%)
Closing price 04:00 PM Eastern
Extended Trading
$7.98 0.00 (0.00%)
As of 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Eton Pharmaceuticals stock logo

Eton Pharmaceuticals NASDAQ:ETON

$15.37 +0.08 (+0.52%)
Closing price 04:00 PM Eastern
Extended Trading
$15.49 +0.12 (+0.77%)
As of 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Gossamer Bio stock logo

Gossamer Bio NASDAQ:GOSS

$1.78 -0.09 (-4.81%)
Closing price 04:00 PM Eastern
Extended Trading
$1.79 +0.01 (+0.56%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.